The aim of this review is a comprehensive analysis of the current literature concerning the role of autoantibodies (anti-PLA2R/anti-THSD7A) in the pathogenesis of membranous nephropathy and their use in the diagnostic and therapeutic process monitoring. This evidence concerns the gene THSD7A and membranous glomerulonephritis.